pentobarbital will decrease the extent or influence of venetoclax by impacting hepatic/intestinal enzyme CYP3A4 metabolism.Nembutal is a barbiturate used for the therapy of a range of disorders, like fever, seizures, and insomnia. It is manufactured by SanofiAventis[1], previously Novartis AG. It is a popular decision of medication as a consequence